75 computational-physics-simulation-"Prof"-"Prof" Fellowship positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
cilia and nuclear signaling in the brain. Position Summary: We seek a candidate with strong expertise in microscopy and computational image analysis to: Support and enhance ongoing imaging projects in
-
the Department of Inflammation and Ageing at the University of Birmingham. The successful candidate will work to deliver high level computational analysis of immune cell subsets in patients with cutaneous lupus
-
computational biology and immunology are also welcome. Our laboratory focus ranges from the study of basic biological processes to very translational bench-to-clinical research with implementation of laboratory
-
-cell genomics/computer science (AI), neuroscience, vascular biology, developmental biology, cancer biology, immunology, biology/biomedicine, pharmacy, biomedical engineering, or related fields with ample
-
to formulate and lead a research programme that will deliver innovative, world-class science in molecular host-microbes interactions or a related field and good knowledge of JIC/NRP research fields, underpinning
-
NIH Cancer Postdoc Fellowships Available Train in the prestigious National Cancer Institute intramural program The Center for Cancer Research (CCR) in the National Cancer Institute has postdoctoral
-
post has arisen to work for 2 years (in the first instance) on a Programme grant joint between UCL, Insititute of Child Health and University of Newcastle entitled INSTINCT-MBINSTINCT MB. The work in the
-
Postdoc Position Available at National Institutes of Health The Intramural Program of the National Institute of Mental Health (NIMH) is a major research component of the National Institutes
-
of the City of Hope Comprehensive Cancer. The Perry laboratory uses structural biology approaches, together with small molecule and fragment-based drug discovery, computer-aided drug discovery
-
oncology grouping sees close to 550 new cases of these cancers a year. There is a large active clinical trials programme that spans phase 1 to phase 3. These patients have a poor prognosis, and this clinic